Severe adverse event leads to suspension of China's Sinovac Covid-19 vaccine trial in Brazil has suspended China’s Sinovac Covid-19 vaccine trial after a severe adverse event occurred on the 29th of October.

The health regulator, Anvisa has not specified where the event took place nor has it given an indication of how long the suspension might last.

Sign Up for nextbigwhat newsletter

Delivered everyday 8 AM. Most comprehensive coverage of the tech ecosystem.

Download, the short news app for busy professionals